Eli Lilly transitioning its drug discovery bioanalytical capability to Advion's Advion BioServices subsidiary

Eli Lilly and Co.

U.S. / Large-Cap Biopharma (>=$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Advion BioSciences Inc.

U.S. / Tools, Services, and Manufacturing

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced